Author archives: Dr. David Kaslow

Dr. David KaslowDr. Kaslow directs the PATH Malaria Vaccine Initiative (MVI). He has more than 25 years of experience in vaccine research and development. Before joining PATH, Dr. Kaslow held key advisory positions with MVI and the Bill & Melinda Gates Foundation related to malaria vaccines. He oversaw project leadership and management of Merck Research Laboratories’ vaccine pipeline and founded the Malaria Vaccine Development Unit at the National Institutes of Health. As a basic research scientist, Dr. Kaslow completed the molecular cloning and characterization of several proteins involved in malaria parasite sexual development. He has directed product development, including field studies, of several malaria vaccine candidates.